×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ONC – beone medicines ltd. - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ONC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/26
06:00 am
onc
U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Low
Report
U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
11/24
09:04 am
onc
BeOne Medicines (NASDAQ:ONC) was given a new $400.00 price target on by analysts at Truist Financial Corporation.
Medium
Report
BeOne Medicines (NASDAQ:ONC) was given a new $400.00 price target on by analysts at Truist Financial Corporation.
11/24
08:43 am
onc
BeOne Medicines (NASDAQ:ONC) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Medium
Report
BeOne Medicines (NASDAQ:ONC) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
11/20
06:00 am
onc
BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025
Medium
Report
BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025
11/18
11:04 am
onc
BeOne Medicines (NASDAQ:ONC) had its price target raised by analysts at Royal Bank Of Canada from $395.00 to $408.00. They now have an "outperform" rating on the stock.
Low
Report
BeOne Medicines (NASDAQ:ONC) had its price target raised by analysts at Royal Bank Of Canada from $395.00 to $408.00. They now have an "outperform" rating on the stock.
11/17
04:11 pm
onc
BeOne Medicines (NASDAQ:ONC) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Medium
Report
BeOne Medicines (NASDAQ:ONC) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
11/17
06:00 am
onc
Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
Low
Report
Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
11/10
04:52 pm
onc
BeOne Medicines (NASDAQ:ONC) had its price target raised by analysts at Citigroup Inc. from $399.00 to $405.00. They now have a "buy" rating on the stock.
Medium
Report
BeOne Medicines (NASDAQ:ONC) had its price target raised by analysts at Citigroup Inc. from $399.00 to $405.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2025
06:00 am
onc
beone medicines ltd. - american depositary shares
BEAT
Report
3.5%
beone medicines ltd. - american depositary shares
8/6/2025
06:00 am
onc
beone medicines ltd. - american depositary shares
BEAT
Report
-2.3%
beone medicines ltd. - american depositary shares
5/7/2025
06:00 am
onc
beone medicines ltd. - american depositary shares
BEAT
Report
-1.3%
beone medicines ltd. - american depositary shares
2/27/2025
06:00 am
onc
beone medicines ltd. - american depositary shares
MISS
Report
4.7%
beone medicines ltd. - american depositary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/1
04:58 pm
onc
Form 4 BeOne Medicines Ltd. For: Nov 26 Filed by: Sanders Corazon (Corsee) D.
Low
Report
Form 4 BeOne Medicines Ltd. For: Nov 26 Filed by: Sanders Corazon (Corsee) D.
11/19
04:58 pm
onc
Form 4 BeOne Medicines Ltd. For: Nov 17 Filed by: Wu Xiaobin
Low
Report
Form 4 BeOne Medicines Ltd. For: Nov 17 Filed by: Wu Xiaobin
11/14
05:35 pm
onc
Form 4 BeOne Medicines Ltd. For: Nov 12 Filed by: Wu Xiaobin
Low
Report
Form 4 BeOne Medicines Ltd. For: Nov 12 Filed by: Wu Xiaobin
11/14
05:28 pm
onc
Form 4 BeOne Medicines Ltd. For: Nov 12 Filed by: Lee Chan Henry
Low
Report
Form 4 BeOne Medicines Ltd. For: Nov 12 Filed by: Lee Chan Henry
11/12
04:47 pm
onc
Form 4 BeOne Medicines Ltd. For: Nov 07 Filed by: Wang Xiaodong
Low
Report
Form 4 BeOne Medicines Ltd. For: Nov 07 Filed by: Wang Xiaodong
10/10
04:57 pm
onc
Form 4 BeOne Medicines Ltd. For: Oct 08 Filed by: Lee Chan Henry
Low
Report
Form 4 BeOne Medicines Ltd. For: Oct 08 Filed by: Lee Chan Henry
9/18
04:45 pm
onc
Form 4 BeOne Medicines Ltd. For: Sep 16 Filed by: OYLER JOHN
Low
Report
Form 4 BeOne Medicines Ltd. For: Sep 16 Filed by: OYLER JOHN
9/12
04:39 pm
onc
Form 4 BeOne Medicines Ltd. For: Sep 10 Filed by: Lee Chan Henry
Low
Report
Form 4 BeOne Medicines Ltd. For: Sep 10 Filed by: Lee Chan Henry
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: